scispace - formally typeset
Search or ask a question
Journal Article•DOI•

Psammocarcinoma of ovary with serous cystadenofibroma of contralateral ovary: a case report

Deepali Jain1, L Akhila1, Vibha Kawatra1, Pallavi Aggarwal1, Nita Khurana1 •
Maulana Azad Medical College1
15 Dec 2009-Journal of Medical Case Reports (BioMed Central)-Vol. 3, Iss: 1, pp 9330-9330
TL;DR: This is the rare case describing coexistence of this very rare malignant serous epithelial tumor with a benign serous cystadenofibroma of contralateral ovary in a 55 year old Asian Indian female.
Abstract: Introduction Psammocarcinoma of ovary is a rare serous neoplasm characterized by extensive formation of psammoma bodies, invasion of ovarian stroma, peritoneum or intraperitoneal viscera, and moderate cytological atypia. Extensive medlar search showed presence of only 28 cases of psammocarcinoma of ovary reported till date.

Content maybe subject to copyright    Report

Citations
More filters
Journal Article•DOI•
Ovarian and peritoneal psammocarcinoma: Results of a multicenter study on 25 patients.

[...]

Jean-Baptiste Delhorme1, Jean-Baptiste Delhorme2, Jordan Ohayon1, Sebastien Gouy1, Gerlinde Averous2, Catherine Genestie1, Léopold Gaichies1, Olivier Glehen, Jean-Marc Guilloit, Denis Pezet, François Quenet, Gwenael Ferron3, Cécile Brigand2, Philippe Morice1, Charles Honoré1, Julio Abba4, Karine Abboud5, Mohammad Alyami6, Catherine Arvieux4, Naoual Bakrin6, G. Balague, Vincent Barrau, Houda Ben Rejeb, J.M. Bereder, Isabelle Berton-Rigaud, Frédéric Bibeau7, Isabelle Bonnefoy6, Dominique Bouzard, I. Bricault4, S. Carrere, Cécile de Chaisemartin, Madleen Chassang, Anne Chevallier, Thomas Courvoisier, Peggy Dartigues1, Anthony Dohan, Julien Dubreuil6, Frédéric Dumont, Clarisse Eveno, Marie Faruch-Bilfeld, Juliette Fontaine6, Laure Fournier, Johan Gagnière, Delphine Geffroy, Laurent Ghouti, François-Noël Gilly6, Laurence Gladieff, Diane Goéré1, Aymeric Guibal, Frédéric Guyon, Bruno Heyd, Christine Hoeffel8, Constance Hordonneau, S. Isaac6, Peggy Jourdan-Enfer6, R. Kaci, R. Kianmanesh8, Catherine Labbé-Devilliers, Joëlle Lacroix, Bernard Lelong, Agnès Leroux-Broussier, Yoann Lherm, Rea Lo Dico, Gérard Lorimier, Caroline Malhaire9, Frédéric Marchal10, Pascale Mariani9, Emilie Mathiotte, Pierre Meeus, Eliane Mery, Simon Msika, Cédric Nadeau11, Pablo Ortega-Deballon, Guillaume Passot6, Olivier Pellet, P. Peyrat, Nicolas Pirro, Marc Pocard, Flora Poizat, Jack Porcheron, Anaïs Poulet6, Patrick Rat, Pierre Rousselot, P. Rousset6, Hélène Senellart, Martine Serrano6, Vincent Servois9, Olivia Sgabura, Andrea Skanjeti6, Magali Svrcek, Raphaël Tetreau, Emilie Thibaudeau, Yann Touchefeu, Jean-Jacques Tuech, Séverine Valmary-Degano, Delphine Vaudoyer6, Stéphane Velasco, Véronique Verriele-Beurrier, Laurent Villeneuve, Romuald Wernert, Franck Zinzindohoué •
Institut Gustave Roussy1, University of Strasbourg2, DuPont3, University of Grenoble4, Jean Monnet University5, Lyon College6, University of Caen Lower Normandy7, Reims University8, Curie Institute9, University of Lorraine10, University of Poitiers11
01 May 2020-Ejso
TL;DR: Complete cytoreductive surgery is the cornerstone of the PK's management as a primary treatment and was associated with a better OS and DFS in a univariate analysis.
Abstract: Purpose Psammocarcinoma (PK) is a rare disease of unknown origin. We aimed to report the characteristics, management and survival of patients operated on for PK within the French Network for Rare Peritoneal Malignancies (RENAPE) expert centers. Patients and methods All consecutive cases of PK operated within all 26 RENAPE centers between 1997 and 2018 were retrospectively analyzed. Results Twenty-five patients were identified. The median age was 53 years [range 17–78]. None of the patients had extra peritoneal metastases at diagnosis. A median of 6 cycles of carboplatin-based systemic chemotherapy was delivered in 52% preoperatively (n = 13) and 56% postoperatively (n = 14); associated with placlitaxel for 12 patients. All patients were operated on. The median PCI was 23 [0–33]. Eighty-four percent had a complete cytoreductive surgery through digestive (n = 7), spleen (n = 3), pancreas (n = 1) resections and/or multiple peritonectomies (n = 11). Five patients (20%) had intraperitoneal chemotherapy. Morbidity (Dindo-Clavien ≥3) was 12%. No postoperative death occurred. After a median follow-up of 42 months (range [2–194]), the median overall (OS) and progression-free (DFS) survival times were respectively 128 months and 31 months. Eighteen patients recurred (72%), mainly in the peritoneum (n = 16). Four of them (22%) were reoperated. The 5 and 10-year DFS rates were both 20.3%. The 5 and 10-year OS rates were 62% and 51.7%, respectively. A complete cytoreductive surgery was associated with a better OS and DFS in a univariate analysis. Conclusion Complete cytoreductive surgery is the cornerstone of the PK's management as a primary treatment. Recurrence remains common and new adjuvant strategies seem needed.

3 citations

Journal Article•DOI•
Bilateral Serous Psammocarcinoma of Ovary: Rare Variant Low Grade Serous Carcinoma.

[...]

Saubhagya Kumar Jena1, Pritinanda Mishra1, Vandana Mohapatra1, Sweta Singh1•
All India Institute of Medical Sciences1
18 Oct 2015-Case Reports in Obstetrics and Gynecology
TL;DR: A 60-year-old postmenopausal woman who presented with abdominal distension and elevated serum CA-125 suggested malignant ovarian neoplasm is reported, which showed bilateral serous psammocarcinoma of ovary with invasive implants on omentum.
Abstract: Serous psammocarcinoma is a rare variant of serous carcinoma arising from either ovary or peritoneum, characterized by massive psammoma body formation, low grade cytologic features, and invasiveness. Its clinical behavior is similar to serous borderline tumors with relatively favorable prognosis. We report herein a case of a 60-year-old postmenopausal woman who presented with abdominal distension. Contrast enhanced computed tomography (CECT) revealed calcified pelvic masses with ascites. Elevated serum CA-125 (970 U/mL) suggested malignant ovarian neoplasm. Patient underwent exploratory laparotomy with primary debulking surgery. Histopathology showed bilateral serous psammocarcinoma of ovary with invasive implants on omentum. Adjuvant chemotherapy was advised in view of advanced stage disease, although its benefits are poorly defined due to rarity of the tumor. However, patient opted out of it and is now on follow-up.

3 citations

Cites background from "Psammocarcinoma of ovary with serou..."

  • ...These tumors are usually unilateral, but rarely may these be bilateral as in our case [11]....

    [...]

Journal Article•DOI•
Enormous cystic tumor of peritoneal psammocarcinoma exhibiting complete response to Cisplatin and cyclophosphamide after suboptimal cytoreduction: case report and review of the literature.

[...]

Ryoko Takahashi, Yutaka Ueda, Mitsunori Shioji, Shiro Adachi, Hiroshi Ohashi, Eiichi Morii, Katsuyuki Aozasa, Kiyoshi Yoshino, Masami Fujita, Takayuki Enomoto, Tadashi Kimura, Atsushi Tokuhira 
21 Sep 2012-Gynecologic and Obstetric Investigation
TL;DR: This case implies that CP therapy is a potential regimen of postoperative remission-induction therapy for suboptimally resected primary peritoneal psammocarcinoma.
Abstract: Psammocarcinoma is a serous peritoneal tumor arising from the ovary or the peritoneum and characterized by low-grade nuclear features, extensive psammoma bodies, and invasiveness Only 62 cases have ever been documented, 30 primary peritoneal and 32 primary ovarian, most of which presented as small tumors Adjuvant therapies, including chemotherapy and radiation, were performed in 12 of the primary peritoneal cases, without any clear evidence of benefit We present a case of an unusually large primary peritoneal psammocarcinoma with unexpected outcome The patient was a 38-year-old woman with a tumor of the peritoneum which adhered densely to the uterus and rectum and developed into the intra-abdominal cavity and retroperitoneal space After adhesiolysis of the tumor and rectum, suboptimal surgical reduction left a 4 cm × 2 cm tumor segment Postoperative chemotherapy, consisting of paclitaxel and carboplatin (TC) for 1 course, and cyclophosphamide and cisplatin (CP) for 5 courses, was conducted The residual tumor responded completely to the chemotherapy and the patient is alive today, with no evidence of disease 15 months after the surgery Our case implies that CP therapy is a potential regimen of postoperative remission-induction therapy for suboptimally resected primary peritoneal psammocarcinoma

2 citations

Journal Article•DOI•
Hypermetabolic Calcified Lymph Nodes on 18Fludeoxyglucose-Positron Emission Tomography/Computed Tomography in a Case of Treated Ovarian Cancer Recurrence: Residual Disease or Benign Formation?

[...]

Alexandra Nikaki, Athanasios Alexopoulos, Fani Vlachou, Vasiliki Filippi, Ioannis Andreou, Vasiliki Rapti, Konstantinos Gogos, K. Dalianis, Roxani Efthymiadou, V. Prassopoulos 
05 Jun 2016-Molecular Imaging and Radionuclide Therapy
TL;DR: Both CT corrected and uncorrected PET images showed hypermetabolism in the massively calcified lymph nodes in the neck, mediastinum, axilla and abdomen, indicative of active residual disease.
Abstract: The contribution of positron emission tomography/computed tomography (PET/CT) with 18F-fludeoxyglucose (FDG) in evaluating ovarian cancer recurrence even after a prolonged disease-free interval, and in therapy response is well-described. Calcifications observed in CT, although usually attributed to benign conditions, may actually represent active disease. Such an example of calcified formations is psammoma bodies. We present a case of 56-y. o. patient with ovarian cancer relapse at the supraclavicular area 18 years after complete response and disease-free interval. The patient received chemotherapy and underwent 18F-FDG-PET/CT for the evaluation of treatment response. Both CT corrected and uncorrected PET images showed hypermetabolism in the massively calcified lymph nodes in the neck, mediastinum, axilla and abdomen, indicative of active residual disease.

1 citations

Cites background from "Psammocarcinoma of ovary with serou..."

  • ...Although the exact mechanism of psammoma body formation is yet unclear, they are known to be associated with increased apoptotic cell death, BRAF mutation, and normal TP53 function, all of which are more profound in low-grade ovarian serous adenocarcinoma (22,23,24)....

    [...]

  • ...Cases reported in the literature include primary psammocarcinomas of the ovary or peritoneum, or psammoma deposits in benign and malignant conditions such as serous adenocarcinoma of the ovaries, thyroid, meningioma, pancreas and calcifications in metastatic lesions (3,6,14,15,16,20,21,22,25,26)....

    [...]

  • ...The later arise from the ovaries or peritoneum, and certain criteria must be fulfilled in order to characterize a carcinoma with psammoma bodies as psammocarcinomas (22)....

    [...]

  • ...They are also likely to represent a biologic process which leads to degeneration of cancer cells, with consequent death and delay of tumor growth (14,19,21,22)....

    [...]

Journal Article•DOI•
Diagnostic Dilemma During Laparoscopic Cystectomy of Twisted Serous Cystadenofibroma of Ovary in Adolescent Girl – A Case Report with Literature Review

[...]

S. Kayastha, Jamuna Kiran Paudel, Rajiv Kumar Deo, Hari Om Joshi, Sweta Thapa 
16 Feb 2022-MED PHOENIX
TL;DR: A case of twisted right ovarian cyst in 17 years unmarried girl that was clinically and radiologically benign and hence managed laparoscopically and the final histopathology report was benign serous cystadenofibroma is reported.
Abstract: The most ovarian tumor arises from the surface epithelium and the serous tumor is the most common histological variant. Serous cystadenofibroma is a rare variant of serous tumor that comprises both epithelial and fibrous stromal components. They are benign in nature but may often be misinterpreted as malignant nature due to their solid cystic nature with papillary projections. We herein report a case of twisted right ovarian cyst in 17 years unmarried girl that was clinically and radiologically benign and hence managed laparoscopically. Intraoperatively cyst ruptured that released clear serous fluid. During cystectomy, multiple small to large size (maximum 2x2 cm) papillary projections were noted within the uninoculated cyst without any other solid components. With the possibility of a borderline tumor, the patient party was counseled and opted for cystectomy with the possible need for a second surgery. The final histopathology report was benign serous cystadenofibroma.
References
More filters
Journal Article•DOI•
Primary psammocarcinoma of the ovary or peritoneum.

[...]

Olivier Poujade1, Catherine Uzan1, Sebastien Gouy1, Patricia Pautier1, Pierre Duvillard1, Philippe Morice1 •
Institut Gustave Roussy1
01 Jul 2009-International Journal of Gynecological Cancer
TL;DR: Peritoneal or ovarian PSC is a rare low-grade carcinoma characterized by a more favorable prognosis than classic carcinoma, and the place of debulking surgery at the time of initial or recurrent management is important.
Abstract: Background: The aim of this study was to assess the outcomes of patients treated for peritoneal or ovarian psammocarcinoma (PSC). Materials and Methods: Review of patients with PSC who underwent cytoreductive surgery in our institution with a follow-up of more than 18 months (the ovarian or peritoneal tumor was histologically reviewed by our reference pathologist). Results: From 1997 to 2006, 15 patients with PSC were histologically reviewed in our institution. Five of these patients fulfilled the inclusion criteria. Four patients had ovarian PSC, and 1 had peritoneal PSC. Four patients were surgically treated during initial management and another patient at the time of recurrence. All of them underwent complete cytoreductive surgery followed by intraperitoneal chemotherapy in 2 patients and by conventional adjuvant chemotherapy in 1. After a median follow-up of 42 months, 4 of them remain disease-free. Conclusions: Peritoneal or ovarian PSC is a rare low-grade carcinoma characterized by a more favorable prognosis than classic carcinoma. The place of debulking surgery at the time of initial or recurrent management is important.

16 citations

"Psammocarcinoma of ovary with serou..." refers background in this paper

  • ...Extensive search showed presence of only 28 cases of psammocarcinoma of ovary reported till date [1-17] (Table 1)....

    [...]

  • ...Literature search showed presence of only 28 cases of psammocarcinoma of ovary reported till date (Table 1) [1-17]....

    [...]

  • ...Poujade et al [17] 2009 4 19-67 NA NA NA Y...

    [...]

Journal Article•DOI•
Serous psammocarcinoma of the ovary and peritoneum: two case reports and review of the literature

[...]

Ibrahim Alanbay1, Murat Dede1, Yusuf Üstün1, Emre Karaşahin1, Salih Deveci1, Ömer Günhan1, Müfit Cemal Yenen1 •
Military Medical Academy1
01 Jun 2009-Archives of Gynecology and Obstetrics
TL;DR: Primary surgical debulking should be attempted, while the utility of postoperative chemotherapy remains unknown, as two-case reports of a SPC of the ovary and peritoneum and review of the literature.
Abstract: Serous psammocarcinoma (SPC) is a rare variant of ovarian carcinoma or peritoneum that may present with features consistent with malignancy, or tumors of low malignant potential. This is two-case reports of a SPC of the ovary and peritoneum and review of the literature. A 41-year-old woman was referred to our clinic for adnexal mass. Ultrasonography revealed endometrioma. Endometriotic cyst excision and sacrouterine biopsy were performed via laparoscopy. Histological examination revealed endometrioma and psammocarcinoma of the peritoneum. Staging laparotomy was performed. She received six courses of chemotherapy. She has no evidence of disease after 6 years from surgical therapy and chemotherapy. A 50-year-old woman presented with pelvic pain and discomfort in the upper abdomen with nausea and emesis. CT scan showed extensive tumor in the lower abdomen, and free fluid in the abdomen and pelvis which appeared to be an ovarian tumor. She underwent a laparotomy and a right and left ovarian tumor measuring about 20 × 15 and 8 × 8 cm, respectively, were seen. Staging procedure was performed. Microscopic examination revealed SPC of the ovary. Chemotherapy was planned. The biologic behavior of this disease remains unresolved. Primary surgical debulking should be attempted, while the utility of postoperative chemotherapy remains unknown.

15 citations

Journal Article•DOI•
Serous psammocarcinoma of the ovary. Case report and literature review

[...]

E. Pakos, A. Funke, K. Tschubel, U. Pfeifer
01 Nov 1997-Pathologe
TL;DR: DNA image cytometry and assessment of proliferative activity showed an euploid, low proliferating tumor cell population, which underlines the low malignancy of this type of carcinoma, which is comparable to that of serous borderline lesions of the ovary and explains the benign clinical course.
Abstract: We report a rare case of psammocarcinoma which presented as a mass in the lower abdomen of an otherwise asymptomatic woman. Ultrasonographically, the tumor showed extensive calcification and was suspected to be a myoma. DNA image cytometry and assessment of proliferative activity were performed and showed an euploid, low proliferating tumor cell population. This underlines the low malignancy of this type of carcinoma, which is comparable to that of serous borderline lesions of the ovary and explains the benign clinical course.

10 citations

"Psammocarcinoma of ovary with serou..." refers background in this paper

  • ...Literature search showed presence of only 28 cases of psammocarcinoma of ovary reported till date (Table 1) [1-17]....

    [...]

  • ...The right ovary measured 7 × 6 × 2 cms. Cut Page 1 of 6 (page number not for citation purposes) P ag e 2 of 6 (p ag e nu m be r n ot fo r c ita tio n pu rp os es ) Follow up Remarks 1-died 3- lost FU 4- free of disease 42 months NED Adolescent NED 12 months NED Family history of epithelial cancer positive Recurrence 18 months Aggressive, with Cystadenofibromata 2 years NED Omental and peritoneal implant NED after 1 year Bilateral, omental nodule showed the features of invasive implant Recovered Bilateral with cysadenofibromata NA Aggressive NED 4 months stable Jo ur na l o f M ed ic al C as e R ep or ts 2 00 9, 3 :9 33 0 ht tp :// w w w .jm ed ic al ca se re po rts .c om /c on te nt /3 /1 /9 33 0 Table 1: Literature review of primary ovarian psammocarcinomas Author Year No. of cases Age Clinical features CA- 125 units/ml FIGO stage Surgery Chemothearpy Gilks et al [1] 1990 8 36 to 76 (mean of 57) Abdominal pain NA III TAH+ BSO (4 cases) LSO(2 cases) BSO(2 cases) Oment (3/8 cases) Y (1 patient) Kelley et al [2] 1995 1 18 Abdominal pain 25 IIIC TAH, BSO, oment, Y Pakos et al [3] (German) 1997 1 49 Mass in the lower abdomen IA BSO N Powell et al [4] 1998 1 59 Abdominal pain and increasing abdominal girth 118 IIIB TAH, BSO, oment N Poggi et al [5] 1998 1 66 Abdominal Pain nausea vomiting NA IIIB BSO, oment N Cobellis et al [6] 2003 1 48 Referred for leiomyomata uteri Normal IIIA TAH, BSO, oment N Giordano et al [7] 2005 1 66 Abdomino-pelvic mass Elevated IIIB TAH, BSO, oment, Y Rattenmaier et al [8] 2005 1 70 Malaise and abdominal discomfort 25,000 NA AH, BSO N Radin et al [9] 2005 1 60 Diffuse abdominal pain, bloating, diarrhea, and low back pain, 65.2 III Laparotomy, tumor debulking Y Vimplis et al[10] 2006 1 63 Abdominal discomfort and increasing abdominal girth 1,133 IIIB BSO,, SH, oment, Y Hiromura et al [11] 2007 1 73 Lower abdominal distention and pain 464 IIIC AH, BSO, and oment Y of 6 (p ag e nu m be r n ot fo r c ita tio n pu rp os es ) Jo ur na l o f M ed ic al C as e R ep or ts 2 00 9, 3 :9 33 0 ht tp :// w w w .jm ed ic al ca se re po rts .c om /c on te nt /3 /1 /9 33 0 Journal of Medical Case Reports 2009, 3:9330 http://www.jmedicalcasereports.com/content/3/1/9330 section was solid and cystic with cysts ranging in size from 0.4 to 0.5 cm....

    [...]

  • ...Pakos et al [3] (German) 1997 1 49 Mass in the lower abdomen IA BSO N...

    [...]

  • ...Extensive search showed presence of only 28 cases of psammocarcinoma of ovary reported till date [1-17] (Table 1)....

    [...]

  • ...All but one, cases reported in the literature had FIGO stage III tumors showing clinical behavior similar to that of borderline serous tumors [3]....

    [...]

Journal Article•DOI•
Psammocarcinoma of the ovary: a case report and review of the literature

[...]

S. Vimplis1, K. M. Williamson1, Z. Chaudry1, D. Nuuns1•
Nottingham City Hospital1
21 Feb 2006-Gynecological Surgery
TL;DR: The case of a 63-year-old woman who presented with a highly calcified abdominopelvic mass and a raised CA-125 marker and who, following a full staging laparotomy, was diagnosed with stage IIIB ovarian psammocarcinoma is reported.
Abstract: Psammocarcinoma is a rare form of serous carcinoma of the ovary, associated with extensive psammoma body formation and invasion of surrounding structures. We report the case of a 63-year-old woman who presented with a highly calcified abdominopelvic mass and a raised CA-125 marker and who, following a full staging laparotomy, was diagnosed with stage IIIB ovarian psammocarcinoma. Serous ovarian psammocarcinoma is characterized by massive psammoma body formation, and despite the limited number of cases reported, it appears that the clinical prognosis is much more favorable than for the usual serous carcinomas and is similar to that of serous borderline lesions of the ovary. A summary of all the reported cases is provided to highlight the clinical and prognostic features of this rare tumor.

9 citations

"Psammocarcinoma of ovary with serou..." refers background in this paper

  • ...Extensive search showed presence of only 28 cases of psammocarcinoma of ovary reported till date [1-17] (Table 1)....

    [...]

  • ...Literature search showed presence of only 28 cases of psammocarcinoma of ovary reported till date (Table 1) [1-17]....

    [...]

  • ...Vimplis et al[10] 2006 1 63 Abdominal discomfort and increasing abdominal girth 1,133 IIIB BSO,, SH, oment, Y...

    [...]

Journal Article•DOI•
A unique case of ovarian psammocarcinoma with mediastinal, pulmonary, subcutaneous, and omental metastases

[...]

Daniel M. Chase, Dorothy A. Sparks, Melissa Gener, James A. Smith
01 Aug 2009-Archives of Gynecology and Obstetrics
TL;DR: A case of 45-year-old woman with ovarian psammocarcinoma who initially presented with a metastatic subcutaneous nodule, and was found to have pulmonary and mediastinal metastases is presented, believed to be the first report of a psammoarcinomas with these metastases.
Abstract: Psammocarcinoma is a rare form of serous ovarian and peritoneal carcinoma, characterized by abundant psammoma bodies, invasiveness, and low-grade cytological features Many of the cases which have been reported had extraovarian spread and peritoneal seeding at the time of presentation We present a case of 45-year-old woman with ovarian psammocarcinoma who initially presented with a metastatic subcutaneous nodule, and was found to have pulmonary and mediastinal metastases We believe this to be the first report of a psammocarcinoma with these metastases Ovarian and peritoneal psammocarcinomas are quite rare, and because of this, knowledge of their behavior is limited Although most seem to follow an indolent course similar to that of borderline lesions of the ovary, this case demonstrates that some of these tumors may be clinically aggressive with distant metastases

8 citations

"Psammocarcinoma of ovary with serou..." refers background in this paper

  • ...Extensive search showed presence of only 28 cases of psammocarcinoma of ovary reported till date [1-17] (Table 1)....

    [...]

  • ...Despite the apparent low malignant potential of this tumor, there remains a need for patient's follow up data as aggressive behavior has been described in the literature [12,15,16]....

    [...]

  • ...Literature search showed presence of only 28 cases of psammocarcinoma of ovary reported till date (Table 1) [1-17]....

    [...]

  • ...Chase et al [16] 2009 1 45 Subcutaneous nodule NA NA B o...

    [...]

Related Papers (5)
Serous psammocarcinoma of the ovary and peritoneum

[...]

01 Apr 1990-International Journal of Gynecological Pathology
C. B. Gilks, Debra A. Bell, Robert E. Scully
Serous psammocarcinoma of the ovary: CT and MR findings.

[...]

01 May 2007-Journal of Computer Assisted Tomography
Tadao Hiromura, Yumiko Oishi Tanaka, Takeshi Nishioka, Kazuo Tomita 
Psammocarcinoma with an aggressive course

[...]

01 Oct 1998-Obstetrics & Gynecology
Sarah Poggi, Robert E. Bristow, Roberta K. Nieberg, Jonathon S. Berek 
Primary psammocarcinoma of the ovary or peritoneum.

[...]

01 Jul 2009-International Journal of Gynecological Cancer
Olivier Poujade, Catherine Uzan, Sebastien Gouy, Patricia Pautier, Pierre Duvillard, Philippe Morice 
Serous psammocarcinoma of the ovary and peritoneum: two case reports and review of the literature

[...]

01 Jun 2009-Archives of Gynecology and Obstetrics
Ibrahim Alanbay, Murat Dede, Yusuf Üstün, Emre Karaşahin, Salih Deveci, Ömer Günhan, Müfit Cemal Yenen